Myelin oligodendrocyte glycoprotein (MOG) has been identified as a target of demyelinating autoantibodies in animal models of inflammatory demyelinating diseases of the CNS, such as multiple sclerosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback